Table 1.
Low risk | Negative lymph nodes and all the following criteria: |
pT under 2 cm; | |
Histological grade 1; | |
ER or PR positive; | |
HER-2 negative; | |
Molecular subtype luminal A; and | |
Age equal to or above 35 years old. | |
Intermediate risk | Negative lymph nodes and at least one of the following criteria: |
pT higher than 2 cm; or | |
Histological grade 2–3; or | |
ER or PR negative; or | |
Molecular subtype luminal B (HER-2 negative); or | |
Age under 35 years old; or yet | |
1 to 3 affected lymph nodes if ER and PR positive. | |
High risk | 4 or more positive lymph nodes; or |
Lymph nodes negative with ER. PR and HER-2 negative. pT higher than 2 cm; or | |
Lymph node negative. pT higher than 1 cm and HER-2 positive. |
pT: tumor size; ER: estrogen receptor; PR: progesterone receptor; HER-2: human epidermal growth factor receptor 2.